| D Scott Cohen, MD | |
|
5530 Wisconsin Ave, Suite 930, Chevy Chase, MD 20815-4404 | |
| (301) 656-7374 | |
| (301) 656-1019 |
| Full Name | D Scott Cohen |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 5530 Wisconsin Ave, Chevy Chase, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710960794 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | D0042051 (Maryland) | Primary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | MD19202 (Maryland) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| D Scott Cohen, MD Po Box 79170, Baltimore, MD 21279-0170 Ph: (301) 656-7374 | D Scott Cohen, MD 5530 Wisconsin Ave, Suite 930, Chevy Chase, MD 20815-4404 Ph: (301) 656-7374 |
News Archive
A new chemical synthesis method based on a catalyst worth many times the price of gold and providing a far more efficient and economical method than traditional ones for designing and manufacturing extremely novel pharmaceutical compounds is described by its University at Buffalo developers in a review article in the current issue of Nature.
A joint Oxford University/Imperial College research programme into HIV/AIDS has received £5 million support from the Wellcome Trust to carry out a drug trial involving HIV patients in London, Moscow, South Africa and Australia.
Researchers from North Carolina State University have found a link between a mutation in a gene called RAB 24 and an inherited neurodegenerative disease in Old English sheepdogs and Gordon setters. The findings may help further understanding of neurodegenerative diseases and identify new treatments for both canine and human sufferers.
RepRegen™, the ‘smart biomaterials' company previously known as BioCeramic Therapeutics, announced today that data from an in vitro study has demonstrated that its patented Strontium-based bioactive glass platform promotes osteoblast cell activity and proliferation. If in vivo studies, which are currently underway, demonstrate similar results, then RepRegen believes its platform has the potential to significantly improve the repair and regeneration of hard-tissue, such as bone.
› Verified 3 days ago
Dr. Rachel Kaiser, MD, MPH Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5454 Wisconsin Ave, Suite 600, Chevy Chase, MD 20815 Phone: 301-942-7600 | |
Dr. Allen A. Nimetz, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 5530 Wisconsin Ave, Suite 700, Chevy Chase, MD 20815 Phone: 301-656-5050 Fax: 301-654-4237 | |
Dr. Ankit B Shah, M.D., M.P.H. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8401 Connecticut Ave Ste 104, Chevy Chase, MD 20815 Phone: 240-892-7070 Fax: 240-248-0606 | |
Dr. Steve A Burka, MD Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 5530 Wisconsin Ave, #914, Chevy Chase, MD 20815 Phone: 301-654-3803 Fax: 301-654-3808 | |
Dr. Mark A Miller, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 4411 Leland St, Chevy Chase, MD 20815 Phone: 301-496-0815 | |
Dr. Sara Goldkind, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 5630 Wisconsin Ave Apt 807, Chevy Chase, MD 20815 Phone: 240-353-0866 | |
Dr. Robert J Marshall, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5530 Wisconsin Ave Ste 700, Chevy Chase, MD 20815 Phone: 301-656-5050 Fax: 301-654-4237 |